MSB 2.03% $1.45 mesoblast limited

Cell Therapy News/Articles, page-10657

  1. 3,215 Posts.
    lightbulb Created with Sketch. 951
    Yep, I'd be interested.

    Am trying to figure out what other treatments are out there, that we know are safe for under 12s, and have been shown to be effective against Covid MIS-C, and also ARDS bar Ryoncil.

    I see they're doing mono antibodies now on under 12s

    https://www.bostonglobe.com/2021/08/20/metro/what-parents-need-know-about-kids-under-12-monoclonal-antibody-treatments/

    But I also see...

    There is no evidence for safety and efficacy of monoclonal antibody therapy for treatment of COVID-19 in children or adolescents, limited evidence of modest benefit in adults, and evidence for potential harm associated with infusion reactions or anaphylaxis.28 May 2021

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.